Interferon-α improves bone resorption and osteopenia in patients with chronic hepatitis C

Hepatology Research

Volumn 34, Issue 4, 2006, Pages 222-227

  Nishida, Naoshi ^a,b   Komatsu, Yasato ^a   Komeda, Toshiki ^a   Fukuda, Yoshihiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone absorption; Bone mineral density; Chronic hepatitis C; Deoxypyridinoline; Interferon; Osteoporosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHA2B INTERFERON; CREATININE; DEOXYPYRIDINOLINE; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE MINERALIZATION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEPATITIS C; HOMEOSTASIS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS LOAD;

EID: 33645025038     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2006.01.004     Document Type: Article

References (23)

1. H. Yoshida Y. Arakawa M. Sata et. al. Interferon therapy prolonged life expectancy among chronic hepatitis C patients Gastroenterology 123 2002 483-491
2. F. Imazeki O. Yokosuka K. Fukai H. Saisho Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study Hepatology 38 2003 493-502
3. T. Taniguchi K. Ogasawara A. Takaoka N. Tanaka IRF family of transcription factors as regulators of host defense Annu Rev Immunol 19 2001 623-655
4. T. Taniguchi A. Takaoka The interferon-alpha/beta system in antiviral responses: A multimodal machinery of gene regulation by the IRF family of transcription factors Curr Opin Immunol 14 2002 111-116
5. H. Takayanagi S. Kim K. Matsuo et. al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta Nature 416 2002 744-749
6. F. Szalay D. Hegedus P.L. Lakatos et. al. High serum osteoprotegerin and low RANKL in primary biliary cirrhosis J Hepatol 38 2003 395-400
7. T. Taniguchi A. Takaoka A weak signal for strong responses: interferon-alpha/beta revisited Nat Rev Mol Cell Biol 2 2001 378-386
8. R.G. Long E. Meinhard R.K. Skinner et. al. Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease Gut 19 1978 85-90
9. V.J. Desmet M. Gerber J.H. Hoofnagle M. Manns P.J. Scheuer Classification of chronic hepatitis: Diagnosis, grading and staging Hepatology 19 1994 1513-1520
10. T. Miki H. Yoshida A. Shioi et. al. Effect of interferon α on calcium and bone metabolism in patients with chronic hepatitis J Bone Miner Met 11 1993 39-44
11. J.A. Solis-Herruzo G. Castellano I. Fernandez R. Munoz F. Hawkins Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C J Hepatol 3 2000 812-817
12. A. Trombetti E. Giostra G. Mentha F. Negro R. Rizzoli Lack of evidence for ribavirin-induced bone loss Hepatology 36 2002 255-257
13. A. Tsubota Y. Arase F. Suzuki et. al. High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline load J Gastroenterol 39 2004 155-161
14. C. Qian J. Camps M.D. Maluenda M.P. Civeira J. Prieto Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy J Hepatol 16 1992 380-383
15. T.T. Chang K.C. Young Y.J. Yang H.Y. Lei H.L. Wu Hepatitis C virus RNA in peripheral blood mononuclear cells: Comparing acute and chronic hepatitis C virus infection Hepatology 23 1996 977-981
16. M. Radkowski J. Wilkinson M. Nowicki et. al. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: Evidence of replication J Virol 76 2002 600-608
17. M. Radkowski A. Bednarska A. Horban et. al. Infection of primary human macrophages with hepatitis C virus in vitro: Induction of tumour necrosis factor-alpha and interleukin 8 J Gen Virol 85 2004 47-59
18. T.N. Pham S.A. MacParland P.M. Mulrooney et. al. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C J Virol 78 2004 5867-5874
19. M.H. Heim D. Moradpour H.E. Blum Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway J Virol 73 1999 8469-8475
20. F.H. Duong M. Filipowicz M. Tripodi N. La Monica M.H. Heim Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A Gastroenterology 126 2004 263-277
21. A. Blindenbacher F.H. Duong L. Hunziker et. al. Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice Gastroenterology 124 2003 1465-1475
22. L.F. Coelho G. Magno de Freitas Almeida F.J. Mennechet A. Blangy G. Uze Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression Proc Natl Acad Sci USA 102 2005 11917-11922
23. T. Okanoue Y. Itoh T. Kirishima et. al. Transient biochemical response in interferon therapy decreases the development of hepatocellular carcinoma for five years and improves the long-term survival of chronic hepatitis C patients Hepatol Res 23 2002 62-77